Keebeck Wealth Management Takes $598,000 Position in The Allstate Corporation $ALL

Keebeck Wealth Management acquired a new position in shares of The Allstate Corporation (NYSE:ALL) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,504 shares of the insurance provider’s stock, valued at approximately $598,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. MV Capital Management Inc. bought a new position in Allstate during the fourth quarter worth about $25,000. Gables Capital Management Inc. bought a new stake in Allstate in the second quarter valued at approximately $26,000. Navalign LLC bought a new stake in Allstate in the fourth quarter valued at approximately $27,000. Kelleher Financial Advisors acquired a new stake in shares of Allstate in the second quarter valued at approximately $28,000. Finally, Evolution Wealth Management Inc. lifted its position in shares of Allstate by 7,000.0% in the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after buying an additional 140 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Insider Transactions at Allstate

In other news, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John E. Dugenske sold 32,996 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the sale, the insider directly owned 13,054 shares of the company’s stock, valued at approximately $3,515,833.82. The trade was a 71.65% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 91,446 shares of company stock valued at $24,208,675. 1.55% of the stock is currently owned by corporate insiders.

Allstate News Summary

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on Allstate from $282.00 to $292.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Wall Street Zen raised Allstate from a “hold” rating to a “buy” rating in a report on Monday, July 20th. Morgan Stanley set a $265.00 price objective on shares of Allstate in a research report on Tuesday, August 11th. HSBC downgraded shares of Allstate from a “buy” rating to a “hold” rating and upped their price objective for the company from $244.00 to $264.00 in a report on Monday, July 6th. Finally, Evercore set a $240.00 price objective on shares of Allstate in a research report on Friday, July 10th. Four research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of “Hold” and an average target price of $265.26.

Allstate Price Performance

Allstate stock opened at $253.82 on Friday. The company has a market capitalization of $64.18 billion, a price-to-earnings ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22. The stock’s 50 day moving average is $250.34 and its 200-day moving average is $224.95.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, topping the consensus estimate of $6.06 by $2.93. The business had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The firm’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period last year, the firm posted $5.94 EPS. Equities research analysts expect that The Allstate Corporation will post 34.45 EPS for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Allstate Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.